Screening of a new gene C-12 coding for a hepatitis B virus core antigen interacting protein in hepatocytes by yeast-two hybrid technique

World Chinese Journal of Digestology

Volumn 11, Issue 12, 2003, Pages 1862-1865

  Liang, Yao Dong ^a   Lu, Yin Ying ^a   Cheng, Jun ^a   Li, Qiang ^a   Wang, Lin ^a   Wu, Jun ^b   Cheng, Ming Liang ^b  

^a BEIJING 302 HOSPITAL   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOLACTATE SYNTHASE; APOLIPOPROTEIN M; BLOOD CLOTTING FACTOR 9; C 12 INTERACTING PROTEIN; CALPAIN LIKE PROTEASE; CATHEPSIN B; CLASS Q PROTEIN; CYTOCHROME C OXIDASE II; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 5; FERRITIN LIGHT POLYPEPTIDE; GENE PRODUCT; GLYCAN; HEPATITIS B CORE ANTIGEN; HEPATITIS B VIRUS CORE ANTIGEN INTERACTING PROTEIN; INTER ALPHA GLOBULIN INHIBITOR; KH TYPE SPLICING REGULATORY PROTEIN; METALLOTHIONEIN II; ORNITHINE DECARBOXYLASE 1; PHOSPHATIDYLINOSITOL; PROTEIN H4; PROTEIN TYROSINE KINASE EPHB4VL; TRANSCRIPT VARIANT 1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BIOINFORMATICS; C 12 GENE; CULTURE MEDIUM; DIPLOIDY; DNA LIBRARY; FUNGAL GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; HEPATITIS B VIRUS; LIVER CELL; MOLECULAR CLONING; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE AH109; SACCHAROMYCES CEREVISIAE Y187; TWO HYBRID SYSTEM; VIRUS GENE; YEAST;

EID: 0346733178     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pumpens P, Grens E. Hepatitis B core particles as a universal display model: a structure-function basis for development. FEBS Lett 1999;442:1-6
2. Le Pogam S, Shih C. Influence of a putative intermolecular interaction between core and the pre-S1 domain of the large envelope protein on hepatitis B virus secretion. J Virol 2002;76:6510-6517
3. Daub H, Blencke S, Habenberger P, Kurtenbach A, Dennenmoser J, Wissing J, Ullrich A, Cotten M. Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. J Virol 2002;76:8124-8137
4. Duclos-Vallee JC, Capel F, Mabit H, Petit MA. Phosphorylation of the hepatitis B virus core protein by glyceraldehyde-3-phosphate dehydrogenase protein kinase activity. J Gen Virol 1998;79(Pt 7):1665-1670
5. Kau JH, Ting LP. Phosphorylation of the core protein of hepatitis B virus by a 46-kilodalton serine kinase. J Virol 1998;72:3796-3803
6. Lu YY, Li K, Cheng J, Wang L, Liu Y, Duan HJ, Zhang LX. Cloning and expression of hepatitis B virus X gene in yeast. Shijie Huaren Xiaohua Zazhi 2002;10:15-18
7. Wang L, Li K, Cheng J, Lu YY, Wang G, Liu Y, Zhong YW, Duan HJ, Hong Y. Screening and cloning of the genes of protein interacting with human augmenter of liver regeneration. Shijie Huaren Xiaohua Zazhi 2002;10:161-164
8. Li K, Wang L, Cheng J, Zhang LX, Duan HJ, Lu YY, Yang JZ, Liu Y, Hong Y, Xia XB, Wang G, Dong J, Li L, Zhong YW, Chen JM. Screening and cloning of gene of hepatocyte protein 1 interaction with HCV core proyein. Shijie Huaren Xiaohua Zazhi 2001;9:1379-1383
9. Li K, Wang L, Cheng J, Lu YY, Zhang LX, Li L, Liu Y, Duan HJ. Expression of NS2 gene of hepatitis C virus from yeast two hybrid 'Bait' vector in yeast. Shijie Huaren Xiaohua Zazhi 2002;10:129-132
10. Lu YY, Wang L, Cheng J, Li K, Lu Y, Zhang LX. Screening of HBcAg antigen interacting proteins in hepatocytes with yeast-two hybrid technique. Shijie Huanren Xiaohua Zazhi 2003;11:426-429
11. Lu YY, Wang L, Li K, Liu Y, Cheng J, Zhang LX. Screening and cloning of gene antigen HBcAg interacting proteins in hepatocytes. Shijie Huaren Xiaohua Zazhi 2003;11:422-425
12. Zhuang L, You J, Tang BZ, Ding SY, Yan KH, Peng D, Zhang YM, Zhang L. Preliminary results of thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B. World J Gastroenterol 2001;7:407-410
13. He XS, Huang JF, Chen GH, Fu Q, Zhu XF, Lu MQ, Wang GD, Guan XD. Orthotopic liver transplantation for fulminant hepatitis B. World J Gastroenterol 2000;6:398-399
14. Wang Y, Liu H, Zhou Q, Li X. Analysis of point mutation in site 1896 of HBV precore and its detection in the tissues and serum of HCC patients. World J Gastroenterol 2000;6:395-397
15. Qin LL, Su JJ, Li Y, Yang C, Ban KC, Yian RQ. Expression of IGF-II, p53, p21 and HBxAg in precancerous events of hepatocarcinogenesis induced by AFB1 and/or HBV in tree shrews. World J Gastroenterol 2000;6:138-139
16. Cheng ML, Wu YY, Huang KF, Luo TY, Ding YS, Lu YY, Liu RC, Wu J. Clinical study on the treatment of liver fibrosis due to hepatitis B by IFN-alpha(1) and traditional medicine preparation. World J Gastroenterol 1999;5:267-269
17. Wang XZ, Jiang XR, Chen XC, Chen ZX, Li D, Lin JY, Tao QM. Seek protein which can interact with hepatitis B virus X protein from human liver cDNA library by yeast two-hybrid system. World J Gastroenterol 2002;8:95-98
18. Nagpal S, Ghosn CR, Chandraratna RA. Identification of nuclear receptor interacting proteins using yeast two-hybrid technology. Methods Mol Biol 2001;176:359-376
19. Serebriiskii IG, Toby GG, Finley RL Jr, Golemis EA. Genomic analysis utilizing the yeast two-hybrid system. Methods Mol Biol 2001;175:415-454
20. Gietz RD, Woods RA. Screening for protein-protein interactions in the yeast two-hybrid system. Methods Mol Biol 2002;185:471-486
21. Zhen Z. Progress in proteomics. Shengwu Gongcheng Xuebao 2001;17:491-493
22. Okazaki Y, Namikawa K, Minami T. Studies of metals and metallothionein in tissue. Yakugaku Zasshi 2000;120:282-289
23. Smolarek C, Stremmel W. Therapy of Wilson disease. Z Gastroenterol 1999;37:293-300
24. Min H, Turck CW, Nikolic JM, Black DL. A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev 1997;11:1023-1036
25. Ring HZ, Vameghi-Meyers V, Nikolic JM, Min H, Black DL, Francke U. Mapping of the KHSRP gene to a region of conserved synteny on human chromosome19p13.3 and mouse chromosome 17. Genomics 1999;56:350-352
26. Bayraktar Y, Koseoglu T, Temizer A, Kayhan B, Van Thiel DH, Uzunalimoglu B. Relationship between the serum alanine aminotransferase level at the end of interferon treatment and histologic changes in wild-type and precore mutant hepatitis B virus infections. J Viral Hepat 1996;3:137-142
27. Bayraktar Y, Saglam F, Temizer A, Uzunalimodlu B, van Thiel DH. The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B. Hepatogastroenterology 1998;45:2322-2327
28. Cao Z, Bai Y, Yang X, Liu J, Li B, Li F. Study of iron metabolism abnormality in the hepatocyte damage of hepatitis B. Zhonghua Ganzangbing Zazhi 2001;9:37-39
29. Mandishona E, MacPhail AP, Gordeuk VR, Kedda MA, Paterson AC, Rouault TA, Kew MC. Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology 1998;27:1563-1566
30. Piperno A, Fargion S, D'Alba R, Roffi L, Fracanzani AL, Vecchi L, Failla M, Fiorelli G. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 1992;16:364-368
31. Dimitrijevic J, Bojanic N, Skaro-Milic A, Mijuskovic P, Ilic S, Nozic D. Morphologic characteristics of HBV markers and products of iron metabolism in liver tissue in patients with hepatitis B virus. Vojnosanit Pregl 1992;49:477-483